New drug delivery system for cancer chemotherapy using lipid commpositions characteristic of cancer cell membrane
New drug delivery system for cancer chemotherapy using lipid commpositions characteristic of cancer cell membrane
批准号:
04807145
负责人:
OKAMOTO Tetsuji
金额:
$1.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993
中文摘要
已知抗癌药物的作用依赖于靶癌细胞的组织学分型。我们推测frug效应的异质性是由于靶癌细胞的膜疏水性不同造成的。膜脂组成是决定膜疏水性的主要因素之一。在第一年的研究中,我们在无血清细胞培养中研究了几种口腔鳞状细胞癌(SCC)和唾液腺源性腺癌细胞(SAC)的脂质代谢和脂质组成。我们发现SCC总膜脂的80%是磷脂,20%是游离胆固醇。另一方面,SAC总膜脂的80%为甘油三酯和酯化胆固醇等中性脂质,20%为磷脂,这些结果明显表明SCC膜的脂质组成与SAC不同,表明SCC膜的疏水性高于SAC膜。在第二年的研究中,我们研究了博来霉素(BLM)、培霉素(PLM)、顺铂(CDDP)和卡铂(CDBCA)对几种SCC和SAC在无werum细胞培养中的生长的影响,BLM和PLM对SCC的细胞毒活性强于SAC。CDDp和CDBCA对SAC的活性强于对SCC的活性。此外,这些活性依赖于药物的细胞内浓度。这些结果强烈提示抗癌药物的细胞毒作用依赖于癌细胞膜的疏水性。我们目前正计划研究与靶细胞膜脂质组成相同的膜脂复合抗癌药物脂质体的作用。
英文摘要
It has been known that the effects of anti cancer drug is dependent of histological typing of the target cancer cells. We have speculated that the heterogeneity of the frug effect is resulted from the defference of membrane hydrophobicity of the target cancer cells. One of major factors determine membrace hydrophobicity membrane lipid compositions.On the first research year, we have studied lipid metabolism and lipid compositions of several oral squamous cell carcinoma cells(SCC) and salibary gland derived adenocarcinoma cells(SAC) in serum-free cell culture. We have found that 80% of total SCC membrane lipid is phosphokipid and 20% is free cholesterol. On the other hand, 80% of total SAC membrane lipid is meutral lipid such as trigriceride and eaterified cholesterol, and 20% is phospholipid, these results apparently revealed that the lipid composition of SCC membrane is defferent from that of SAC and suggest that hydrophobicith of SCC membrane is higher than that of SAC membrane.On the second research year, we have studied the effects of bleomycin (BLM), peplomycin(PLM), cis-platinum(CDDP) and carboplatin(CDBCA) on the growth of weveral SCC and SAC in werum-free cell culture, the cytotoxic activities of BLM and PLM on SCC are stronger than these on SAC.On the other hand, the activities of CDDp and CDBCA on SAC are stronger than these on SCC.Furthermore, these activities are dependent on the intra-cellular concentration of the drugs. These results strongly suggest that cytotoxic effect of anticancer drug are dependent on the hydrophobicity of the cancer cell membrane. We are currently planning to study the effect of lipisome that is complexed anticancer drug with membrane lipid which is the same as lipid composition of target cell membrane.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
岡本哲治: "雄性マウス顕下腺におけるFGF-1の機能とテストステロン依存性" 日本口腔組織培養研究会誌. Vol.3. 37-38 (1994)
Tetsuji Okamoto:“雄性小鼠亚临床腺体中的 FGF-1 功能和睾酮依赖性”日本口腔组织培养研究会杂志第 3 卷 37-38(1994 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
J.D.Sato, T.Okamoto, et al: Basic Animal Cell Cutrure : A prectical approach. Oxford Univ. Press, (1994)
J.D.Sato、T.Okamoto 等人:基本动物细胞培养:一种预科方法。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Toratani, T.Okamoto, et al: "A study of photodynamic therapy against human oral cancer cells using a new photosensitizwe(pheophorbide-a)" Jpn. J.Oral Maxillofac. Surg.Vol.38. 729-736 (1992)
S.Toratani、T.Okamoto 等人:“使用新型光敏剂(脱镁叶绿酸-a)对人类口腔癌细胞进行光动力疗法的研究”Jpn。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
岡本哲治: "雄性マウス顎大腺におけるFGF-1の機能とテストステロン依存性" 日本口腔組織培養研究会誌. Vol 3. 37-38 (1994)
Tetsuji Okamoto:“雄性小鼠大颌腺中的 FGF-1 功能和睾酮依赖性”日本口腔组织培养研究会杂志第 3 卷 37-38(1994 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y.Fujita, T.Okamoto, et al: "Anovel heparin-binding protein, HBp15 is indentified as mammalian rebosomal protein L22." Biochem. Biophys. Res. Commun. (in press). (1994)
Y.Fujita、T.Okamoto 等人:“新型肝素结合蛋白 HBp15 被鉴定为哺乳动物核糖体蛋白 L22。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 23 条
Induction of Jaw Bone and Tooth Germ from murine embryonic stem cells and human bone marrow stem cells in serum-free defined suspension culture
-
批准号:22659369
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.07万
-
财政年份:2010
-
负责人:OKAMOTO Tetsuji
-
依托单位:
Identification of Cancer Stem Cell and its niche system in Oral Cancer
-
批准号:21390539
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.65万
-
财政年份:2009
-
负责人:OKAMOTO Tetsuji
-
依托单位:
A Molecular-epidemiological study of oral and maxillofacial disease among the residents living in Semipalatinsk nuclear test site in Kazakhstan
-
批准号:20406030
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.57万
-
财政年份:2008
-
负责人:OKAMOTO Tetsuji
-
依托单位:
A Molecular-epidemiological Study of Oral and Maxillofacial Anomalies among the residents in Semipalatinsk Nuclear Test site in Kazakhstan
-
批准号:16406035
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.98万
-
财政年份:2004
-
负责人:OKAMOTO Tetsuji
-
依托单位:
Search for Molecular Targets by Proteome Analysis and Its Use to Taylored-Made Therapy against Oral Cancer
-
批准号:15390615
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.47万
-
财政年份:2003
-
负责人:OKAMOTO Tetsuji
-
依托单位:
Development of Gene diagnosis of Oral-Maxillofacial Deseases by Saliva-derived DNA
-
批准号:13557177
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.02万
-
财政年份:2001
-
负责人:OKAMOTO Tetsuji
-
依托单位:
Molecular Epidemiological studu of Oral and Maxillofacial disorders among the residents of the Semipalatinsk Nuclear Test Site Area
-
批准号:12576025
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.54万
-
财政年份:2000
-
负责人:OKAMOTO Tetsuji
-
依托单位:
Gene Diagnosis/Therapy of Oral Cancer Targetted for Autocrine Growth Factor and Angiogenic Factor Genes
-
批准号:11470437
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$10.11万
-
财政年份:1999
-
负责人:OKAMOTO Tetsuji
-
依托单位:
Gene Diagnosis and Therapy of Salivary Gland Tumors Targetted for FGFR genes
-
批准号:11557161
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.58万
-
财政年份:1999
-
负责人:OKAMOTO Tetsuji
-
依托单位:
Expressionand Regulation of Autocrineand Angiogenic Factors produced by Oral Cancer
-
批准号:09470455
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.42万
-
财政年份:1997
-
负责人:OKAMOTO Tetsuji
-
依托单位:
A STUDY OF GENETHERAPY AGAINST ORAL CANCER TARGETTED TO THE GENE OF AUTOCRINE GROWTH FACTOR
-
批准号:07807184
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1995
-
负责人:OKAMOTO Tetsuji
-
依托单位:
Novel cancer therapy using human monoclonal antibody against human epidermal growth factor receptor
-
批准号:02807185
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.02万
-
财政年份:1990
-
负责人:OKAMOTO Tetsuji
-
依托单位:
国内基金
海外基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
-
批准号:30840003
-
项目类别:专项基金项目
-
资助金额:12.0万元
-
批准年份:2008
-
负责人:焦宇飞
-
依托单位: